Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Study to Evaluate the Feasibility and Efficacy of an Online Resilience Intervention in the General Population ("resiLIR Basic")

NCT05812729 is registered in ClinicalTrials.gov with Leibniz-Institut für Resilienzforschung (LIR) gGmbH as lead sponsor.

NCT NCT05812729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05812729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Study to Evaluate the Feasibility and Efficacy of an Online Resilience Intervention in the General Population ("resiLIR Basic")
Lead sponsor
Leibniz-Institut für Resilienzforschung (LIR) gGmbH
Phase
Not applicable
Overall status
Completed
Start date
June 14, 2023
Completion date
June 28, 2024
Enrollment
244 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

resilience